This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS_EXALLC for full statistics.
Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS
lymphoma: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
314 |
4. Check minimum number of eventsNone |
314 |
5. Include endpointsNone |
314 |
6. Filter based on genotype QC (FinnGen only) |
314 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- C81-C96
- Name in latin
- Neoplasmata maligna alia et non specificata textus lymphatici, haematopoetici et cognati
Similar endpoints
↥List of similar endpoints to
Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
based on the number of shared cases.
Similar with more cases:
- Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 314 | 146 | 168 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 55.73 | 53.03 | 58.08 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 289
- Matched controls
- 2887
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
155.7
135
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
42.7
122.1
156
77
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
+∞
43.9
41
*
XW000
NOMESCO Finland
Bone marrow biopsy
14.7
41.7
73
65
L03AA02
ATC
filgrastim; parenteral
16.4
32.4
53
39
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
30.5
31.6
42
16
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
10.4
28.5
58
68
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
27.2
115
360
C96.2
ICD-10 Finland
Malignant mast cell tumour
+∞
25.4
24
*
WW500
NOMESCO Finland
Blood transfusion
11.7
24.4
46
46
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
23.9
24.1
34
16
20199
ICD-8 Finland
Hodgkin's disease
260.7
24.0
24
*
JN4BD
NOMESCO Finland
Extensive body CT
5.2
23.9
84
212
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.6
22.9
56
88
A04AA01
ATC
ondansetron; systemic, rectal
7.1
21.0
54
91
C96.7
ICD-10 Finland
Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
20.0
19
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
28.4
19.5
26
10
Q82.2
ICD-10 Finland
Mastocytosis
107.1
18.8
20
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
202.6
18.8
19
*
R50.9
ICD-10 Finland
Fever, unspecified
4.2
17.7
75
222
ZX120
NOMESCO Finland
Intravenous
5.0
17.2
59
141
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
27.6
17.2
23
9
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
9.7
16.7
34
39
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
63.7
15.9
18
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
20.7
15.8
23
12
1XC02
NOMESCO Finland
NA
33.7
15.0
19
6
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
10.3
14.8
29
31
M04AA01
ATC
allopurinol; systemic
3.6
14.7
77
268
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
17.3
13.7
21
13
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
14.0
12.6
21
16
C91.4
ICD-10 Finland
Hairy-cell leukaemia
+∞
12.6
12
*
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
+∞
12.6
12
*
20293
ICD-8 Finland
Other neoplasms of lymphoid tissue, Neoplasma benignum sive NUD medullae osseae
+∞
12.6
12
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
12.6
12
*
A02BC02
ATC
pantoprazole; systemic
2.6
12.4
212
1484
N02AA05
ATC
oxycodone; systemic
3.1
12.0
73
280
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
15.5
12.0
19
13
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
11.8
58
191
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
67.8
11.7
13
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
24.1
11.7
16
7
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.1
11.1
30
54
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
62.4
10.7
12
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
114.0
10.5
11
*
2024A
ICD-9 Finland
Other malignant neoplasm of lymphoid and histiocytic tissue, Leukaemic reticuloendotheliosis
+∞
10.5
10
*
H02AB02
ATC
dexamethasone; systemic
3.4
10.4
52
173
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
19.7
10.4
15
8
H02AB06
ATC
prednisolone; systemic
2.2
9.8
159
1027
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
9.8
61
235
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
22.6
9.4
13
6
20228
ICD-8 Finland
Other neoplasms of lymphoid tissue, Other primary malignant neoplasms of lymphoid tissue
+∞
9.4
9
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
9.4
9
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
14.3
9.3
15
11
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
16.9
8.6
13
8
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
34.4
8.1
10
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
22.8
8.1
11
5
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
19.0
7.7
11
6
JN6AD
NOMESCO Finland
CT of torso and neck
12.3
7.7
13
11
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
7.6
79
406
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
7.6
149
1003
9741/3-C42.1
ICD-O-3
Malignant mastocytosis of bone marrow
82.1
7.5
8
*
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
82.1
7.5
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.1
7.3
22
46
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
7.3
7
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
30.8
7.2
9
*
B01AB05
ATC
enoxaparin; parenteral
2.1
7.0
102
603
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
6.9
64
307
JN4AD
NOMESCO Finland
Body CT examination
3.1
6.9
38
134
L03AA13
ATC
pegfilgrastim; parenteral
4.9
6.9
21
45
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
6.6
104
633
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.4
6.5
31
100
ZX090
NOMESCO Finland
Other technic of radiotherapy
5.4
6.4
18
35
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.3
6.3
14
20
2029X
ICD-9 Finland
Other malignant neoplasm of lymphoid and histiocytic tissue, Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue
+∞
6.3
6
*
C96.1
ICD-10 Finland
Malignant histiocytosis
+∞
6.3
6
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
6.3
6
*
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
+∞
6.3
6
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
27.3
6.3
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
6.5
6.2
15
24
WX892
NOMESCO Finland
Monitored bed care
2.9
6.1
36
136
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
182
314
12.41
116.56
8.6
4.5
u/l
284.4
259.2
0.41
175
293
(40768795) Lymph node Pathology biopsy report
60
24
30.67
87.63
1.4
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
64
34
23.39
83.62
1.5
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
106
159
9.55
72.53
1.3
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
49
20
28.85
70.64
1.5
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
126
254
7.62
65.61
1.4
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
58
57
12.25
53.60
1.6
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
123
297
6.16
51.92
1.5
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
129
353
5.51
46.69
1.6
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
206
836
5.26
45.56
10.4
5.6
—
—
—
0
0
(4035726)
102
241
5.79
43.30
1.8
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
237
1175
5.15
38.02
11.1
5.8
%
2.8
2.8
0.08
229
1098
(3019069) Monocytes/100 leukocytes in Blood
237
1182
5.10
37.53
11.3
6.2
%
9.6
8.8
2.14
230
1111
(3022096) Basophils/100 leukocytes in Blood
232
1139
4.97
37.50
11.1
5.9
%
0.7
0.6
0.28
225
1063
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
55
81
8.02
36.92
4.6
4.0
mg/l
47.3
29.5
1.03
46
64
(3002030) Lymphocytes/100 leukocytes in Blood
238
1211
4.99
36.15
11.1
6.0
%
27.3
27.1
0.08
231
1124
(3034860) Kappa light chains.free [Mass/volume] in Serum
54
81
7.84
35.63
4.6
4.0
mg/l
55.0
138.6
0.52
45
64
(3001604) Monocytes [#/volume] in Blood
241
1260
4.93
34.71
10.2
5.6
e9/l
0.6
0.6
0.94
216
1077
(3018010) Neutrophils/100 leukocytes in Blood
234
1199
4.74
34.59
10.4
5.7
%
55.5
57.7
1.50
226
1121
(3006315) Basophils [#/volume] in Blood
241
1270
4.86
34.07
10.2
5.6
e9/l
0.0
0.0
0.14
216
1090
(3013115) Eosinophils [#/volume] in Blood
245
1310
4.96
33.88
10.9
5.9
e9/l
0.2
0.2
0.61
225
1151
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
40
44
10.27
33.74
5.0
7.6
iu/ml
372.2
281.3
—
5
9
(3005719) IgG [Mass/volume] in Serum or Plasma
81
194
5.28
33.16
4.6
2.6
g/l
9.9
10.3
0.19
76
181
(3019198) Lymphocytes [#/volume] in Blood
242
1295
4.79
33.09
10.3
5.7
e9/l
2.0
1.9
0.11
227
1141
(3004588) Protein electrophoresis panel - Serum or Plasma
78
182
5.37
32.89
3.3
2.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
165
681
4.00
32.74
5.7
2.7
umol/l
335.9
6975.4
2.87
158
577
(3027945) Reticulocytes/100 erythrocytes in Blood
107
328
4.43
32.16
3.5
2.8
%
1.7
1.8
1.17
101
292
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
38
42
10.16
31.90
1.5
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
107
6.42
31.38
3.7
2.0
g/l
7.5
7.4
0.07
49
79
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
107
6.29
30.26
3.7
2.0
g/l
3.9
3.7
0.35
48
74
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
107
6.29
30.26
3.7
2.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
55
100
6.46
30.14
3.7
2.0
g/l
3.5
3.2
0.93
49
75
(3013650) Neutrophils [#/volume] in Blood by Automated count
255
1480
4.85
29.66
22.1
9.4
e9/l
4.1
4.2
0.08
239
1299
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
53
95
6.51
29.44
3.7
2.2
g/l
1.1
0.9
0.09
48
82
(3024561) Albumin [Mass/volume] in Serum or Plasma
219
1148
4.00
29.40
9.2
4.8
g/l
33.6
35.2
3.57
213
1065
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
36
42
9.55
28.97
1.5
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
132
507
3.77
28.34
6.4
3.0
mmol/l
2.5
2.5
3.72
125
445
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
34
39
9.66
27.68
1.5
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
115
413
3.82
27.12
5.9
3.3
mmol/l
0.8
0.8
0.24
109
385
(3023520) Reticulocytes [#/volume] in Blood
82
236
4.35
26.30
4.3
3.0
e9/l
67.8
70.9
0.26
61
181
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
239
1390
4.01
26.08
12.9
6.5
umol/l
10.6
12.1
1.48
234
1314
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31
35
9.72
25.49
1.5
1.2
u/ml
237.1
333.4
0.48
20
19
(3011412) CD3 cells [#/volume] in Blood
27
25
11.72
25.45
2.6
1.7
e9/l
1.4
1.2
0.30
21
14
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
20
11
19.35
24.92
3.1
1.5
u/ml
3304.2
821.8
1.30
20
11
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
23
17
14.52
24.77
2.0
1.8
%
16.8
10.3
—
10
8
(40760888) Immunoglobulin light chains.free panel - Serum
38
58
7.32
24.42
5.2
4.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
39
62
7.04
24.15
1.6
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
23
18
13.71
23.97
2.7
1.8
e6/l
387.8
741.9
—
5
8
(3018418) pH of Serum or Plasma
165
798
3.25
23.51
8.4
3.8
ph
7.4
7.4
0.03
37
144
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
22
17
13.84
23.07
2.0
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
141
636
3.21
22.39
18.4
6.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
208
1199
3.18
21.05
10.9
6.2
mmol/l
1.2
1.2
0.04
203
1077
(3015377) Calcium [Moles/volume] in Serum or Plasma
170
880
3.03
20.79
7.8
3.4
mmol/l
2.4
2.4
0.02
156
759
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
219
1307
3.23
20.71
11.8
7.2
mmol/l
1.2
1.2
0.57
185
1111
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
99
377
3.37
20.61
2.4
2.3
%
21.3
22.6
0.37
90
329
(3004789) Transferrin [Mass/volume] in Serum or Plasma
102
398
3.31
20.38
2.3
2.3
g/l
2.2
2.3
1.60
96
368
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
33
54
6.71
19.81
2.1
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
153
771
2.92
19.28
7.9
4.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
105
437
3.11
18.59
2.4
2.3
umol/l
11.8
13.0
0.78
100
402
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
48
119
4.58
18.32
2.0
2.2
g/l
1.4
1.5
0.24
39
103
(3021589) Normoblasts [#/volume] in Blood
191
1103
2.87
18.29
17.8
10.1
e9/l
0.0
0.0
0.61
166
886
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
38
78
5.40
18.08
2.2
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
66
216
3.60
17.16
8.2
4.5
%
1.0
1.0
0.07
41
74
(3037756) Immunofixation for Serum or Plasma
32
60
5.83
16.74
2.0
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
32
7.68
15.89
1.8
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
61
199
3.56
15.87
8.6
4.7
%
0.4
0.2
0.56
37
65
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
75
5.13
15.83
2.1
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
60
194
3.59
15.82
8.2
4.6
%
0.8
0.3
0.96
32
51
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
34
75
4.96
14.86
2.1
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
133
701
2.56
14.34
3.7
3.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
78
313
2.99
14.34
4.6
2.9
umol/l
8.3
9.2
0.18
72
275
(3001122) Ferritin [Mass/volume] in Serum or Plasma
173
1034
2.50
14.18
3.8
2.6
ug/l
373.8
146.9
2.68
165
938
(3030467) Casts [#/volume] in Urine by Automated count
135
735
2.47
13.38
3.9
3.2
e6/l
0.4
0.5
0.25
110
554
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
98
459
2.65
13.33
2.2
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
77
321
2.85
13.11
1.8
1.8
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
32
75
4.64
12.99
3.2
2.4
%
88.6
87.7
0.06
32
70
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
125
667
2.45
12.84
2.1
2.0
mg/l
3.1
3.1
0.07
108
566
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
77
326
2.80
12.70
1.9
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
141
801
2.38
12.51
3.9
3.3
e6/l
45.6
149.6
0.67
117
623
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
24
45
5.69
12.50
1.7
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
59
218
3.10
12.41
7.6
7.0
mmol/l
11.6
10.0
0.63
54
205
(21494434) Karyotype in Bone marrow
20
32
6.61
12.16
1.3
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
53
188
3.19
11.93
7.8
4.8
%
0.0
0.2
0.49
32
55
(3036489) Thrombin time
33
85
4.22
11.89
2.9
2.4
s
21.8
22.0
0.04
33
78
(3000093) Morphology [Interpretation] in Blood Narrative
17
24
7.43
11.53
1.1
1.3
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
11
0
+∞
11.53
1.3
0.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
260
1989
2.79
11.09
18.7
7.7
u/l
91.6
79.6
2.65
254
1851
(3013707) Erythrocyte sedimentation rate by Westergren method
249
1866
2.62
11.07
6.7
4.1
mm/h
18.0
12.7
3.87
239
1697
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
105
552
2.36
10.84
2.2
1.8
mg/l
3.3
1.3
0.60
85
437
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
17
8.57
10.69
1.6
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
60
248
2.75
10.22
4.4
4.0
mmol/l
2.0
2.0
0.01
46
194
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
153
957
2.17
10.21
4.2
3.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
52
201
2.90
10.02
1.9
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
93
480
2.33
9.89
2.6
1.4
g/l
2.3
2.6
0.41
66
288
(3018095) Leukocytes [#/volume] in Urine
148
922
2.14
9.89
4.7
3.8
e6/l
431.8
94.6
0.39
118
666
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
178
1196
2.13
9.69
5.6
4.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
55
224
2.76
9.61
7.8
8.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
20
7.28
9.36
2.8
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
31
91
3.67
9.31
2.0
2.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
136
835
2.11
9.30
4.4
2.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
54
4.52
9.29
1.4
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
54
4.52
9.29
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
73
3.95
9.10
2.9
2.2
u/ml
0.2
0.4
1.65
18
38
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
97
526
2.22
9.07
4.5
3.4
ng/l
280.5
213.6
0.15
79
434
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
65
4.09
8.87
1.3
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
167
1120
2.05
8.86
12.2
10.2
inr
1.3
1.3
0.28
43
310
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
36
121
3.23
8.79
2.2
3.6
u/ml
488.5
1516.2
0.42
25
104
(44790047)
18
36
5.24
8.72
1.4
1.5
—
—
—
0
0
(44806118)
18
36
5.24
8.72
1.4
1.5
—
—
—
0
0
(44790048)
18
36
5.24
8.72
1.4
1.5
—
—
—
0
0
(44790049)
18
36
5.24
8.72
1.4
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
79
400
2.30
8.67
1.8
2.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
13
8
16.87
8.62
2.2
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
13
8
16.87
8.62
1.2
1.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
130
803
2.06
8.59
4.3
3.4
u/l
35.5
32.4
0.42
124
764
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
19
7.09
8.51
1.5
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
16
7.76
8.47
2.7
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
16
7.76
8.47
2.7
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
211
1559
2.08
8.37
7.4
5.1
mmol/l
6.6
6.8
0.53
202
1459
(40768804) Tissue Pathology biopsy report
152
1000
2.01
8.37
2.7
2.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
100
569
2.11
8.16
3.1
2.6
e6/l
5.3
4.9
0.08
92
497
(3026782) Osmolality of Urine
96
539
2.13
8.11
3.3
2.8
mosm/kgh2o
499.1
569.7
3.06
88
449
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
35
5.08
7.98
1.1
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
8
15.53
7.77
2.3
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
95
539
2.09
7.76
9.5
5.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
32
5.21
7.75
2.4
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
157
1066
1.95
7.69
2.1
2.0
pmol/l
87.9
92.8
0.64
94
548
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
81
441
2.13
7.32
3.6
2.9
e6/l
0.8
1.1
0.51
48
256
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
34
4.90
7.25
2.4
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
77
414
2.14
7.18
3.5
3.1
e6/l
1.8
2.0
0.08
43
234
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
48
4.15
7.00
4.3
3.7
%
52.4
58.1
0.71
19
48
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
23
67
3.63
6.98
1.5
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
66
340
2.19
6.83
8.0
7.2
mmol/l
104.3
104.1
0.07
66
335
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
36
4.63
6.79
1.1
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
104
636
1.95
6.76
4.4
2.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
45
4.18
6.72
1.6
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
52
245
2.35
6.64
2.8
2.2
u/l
30.4
33.0
0.20
44
198
(3005322) IgE [Units/volume] in Serum or Plasma
33
126
2.81
6.46
1.3
1.2
u/ml
451.1
202.4
0.64
27
110
(3021960) Folate [Moles/volume] in Serum or Plasma
104
645
1.92
6.44
1.4
1.5
nmol/l
18.7
20.8
0.84
91
536
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
56
3.75
6.42
1.6
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
21
61
3.62
6.40
1.2
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
67
3.46
6.26
1.6
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
43
194
2.41
6.03
4.0
3.8
ng/l
76.5
81.9
0.18
38
170
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
145
1019
1.79
5.89
2.9
2.3
nmol/l
79.6
77.8
0.30
135
880
(3037522) Nuclear Ab [Titer] in Serum
58
301
2.14
5.85
1.6
1.3
titre
1260.0
557.7
0.68
12
70
(3019309) Folate [Moles/volume] in Red Blood Cells
87
523
1.92
5.84
1.8
1.7
nmol/l
995.9
1211.7
1.86
70
383
(21494890) Protein electrophoresis panel - 24 hour Urine
13
28
4.80
5.79
3.1
2.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
41
4.06
5.79
1.1
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
46
3.85
5.72
4.2
3.0
e9/l
3.3
4.6
2.01
17
46
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
123
831
1.79
5.66
2.7
2.6
u/l
49.9
56.5
1.46
108
768
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
58
307
2.09
5.55
2.6
4.4
ug/l
45.7
45.1
0.00
45
260
(3003694) ABO and Rh group [Type] in Blood
99
630
1.83
5.53
1.5
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
18
53
3.54
5.39
1.2
1.5
e6/l
12.9
9.1
0.13
12
41
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
18
53
3.54
5.39
1.2
1.6
e6/l
8.8
219.6
1.03
13
42
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
0
+∞
5.22
2.2
0.0
—
—
—
0
0
(4062490)
11
23
4.92
5.05
1.2
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
23
4.92
5.05
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
41
3.79
4.98
1.1
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
84
2.88
4.89
2.0
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
122
853
1.70
4.81
4.2
3.1
ng/l
1852.5
1561.0
0.38
112
719
(3007853) Bacteria identified in Skin by Aerobe culture
55
303
1.99
4.70
1.7
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
50
268
2.03
4.60
5.6
3.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
25
4.52
4.60
1.1
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
21
4.89
4.56
1.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
217
1782
1.70
4.51
5.1
4.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
19
66
3.00
4.41
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
35
3.83
4.41
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
36
3.72
4.25
4.6
2.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
23
4.46
4.12
3.9
2.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
23
4.46
4.12
1.0
2.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
7
10.19
4.03
2.9
3.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
66
2.83
3.82
1.4
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
20
78
2.67
3.80
3.2
3.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
5
12.19
3.78
1.2
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
25
4.10
3.72
2.2
1.7
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
9
7.92
3.57
2.7
1.6
ug/l
39.0
68.7
—
7
9
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
17
5.42
3.53
1.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
31
3.64
3.51
2.7
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
31
3.64
3.51
2.7
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
31
3.64
3.51
2.7
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
42
3.19
3.41
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
53
320
1.79
3.41
1.4
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
59
371
1.73
3.30
35.3
25.0
inr
1.1
1.3
—
5
48
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
7
8.71
3.27
6.2
5.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
19
4.84
3.26
1.0
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
15
5.44
3.21
2.1
1.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
11
6.48
3.20
2.1
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
55
346
1.71
3.07
1.5
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
16
5.10
3.07
2.1
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
51
2.83
3.02
1.6
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
108
2.22
2.99
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
82
2.40
2.97
1.2
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
46
2.90
2.95
1.2
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
37
209
1.87
2.94
4.7
3.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
10
30
3.41
2.93
1.9
1.5
%
89.1
89.9
—
10
30
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
83
2.37
2.90
1.2
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
9
6.77
2.88
2.8
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
97
2.25
2.84
1.8
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
84
2.34
2.83
1.2
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
31
3.30
2.79
4.5
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
6
8.44
2.76
1.0
1.0
—
—
—
0
0
(3010421) pH of Blood
16
66
2.50
2.75
4.5
3.0
ph
7.4
7.4
0.42
16
57
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
126
2.07
2.74
1.4
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
37
3.04
2.72
1.4
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
202
1731
1.47
2.67
5.3
4.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
32
3.19
2.67
1.4
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
20
4.08
2.58
2.0
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
7
7.24
2.56
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
33
3.10
2.55
8.7
4.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
107
820
1.46
2.52
3.6
3.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
56
804
0.63
2.52
3.2
3.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
26
3.53
2.50
1.7
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
45
2.73
2.48
1.8
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
8
21
3.88
2.48
2.0
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
12
5.07
2.41
3.7
2.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
27
3.40
2.41
3.3
2.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
8
6.33
2.38
5.2
1.5
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
7
17
4.19
2.37
1.4
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
53
2.52
2.31
1.2
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
13
4.68
2.28
1.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
108
2.01
2.21
2.7
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
244
2204
1.48
2.20
34.1
16.8
%
37.2
39.6
4.37
179
1507
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
19
3.74
2.16
5.0
3.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
19
3.74
2.16
1.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
14
4.35
2.16
3.8
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
14
4.35
2.16
3.8
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
14
4.35
2.16
3.8
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
14
4.35
2.16
3.8
1.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
162
1.80
2.10
1.6
1.5
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
9
31
2.96
2.09
1.1
1.5
u/l
388.3
237.7
—
9
31
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
10
5.06
2.08
4.2
2.6
%
13.4
13.6
—
5
10
(3029937) Albumin [Presence] in Urine by Test strip
89
681
1.43
2.07
5.5
4.2
estimate
0.0
0.0
0.00
38
225
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
20
3.55
2.06
1.1
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
271
2513
1.57
2.04
36.1
15.8
mg/l
27.4
24.4
0.93
250
2036
(3019832) Treponema pallidum Ab [Presence] in Serum
26
149
1.81
2.02
1.3
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
32
2.86
2.01
1.2
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
24
135
1.84
1.97
1.3
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
21
3.38
1.97
3.6
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
50
344
1.54
1.96
1.4
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
128
1051
1.37
1.95
4.6
4.0
ng/l
28.2
41.2
1.17
96
782
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
11
4.60
1.95
4.2
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
11
4.60
1.95
4.2
2.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
46
313
1.55
1.90
8.2
9.2
mmol/l
0.9
1.2
0.26
39
250
(3045788) Cell count panel - Pleural fluid
7
22
3.23
1.89
1.6
1.5
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
12
4.22
1.83
1.4
3.3
nmol/l
107.0
60.6
—
5
12
(3035637) Corticotropin [Mass/volume] in Plasma
7
23
3.09
1.81
1.4
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
224
2433
0.72
1.78
4.3
4.6
mmol/l
1.3
1.5
4.61
201
2207
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
48
2.34
1.72
1.1
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
48
0.00
1.71
0.0
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
14
69
2.08
1.67
9.6
2.9
mg/l
2.1
1.6
0.56
14
62
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
233
2506
0.73
1.63
4.9
5.2
mmol/l
2.5
2.7
1.62
206
2270
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
227
2451
0.73
1.63
4.4
4.7
mmol/l
4.3
4.6
2.63
207
2242
(3017704) Immunofixation for Urine
5
14
3.61
1.62
1.8
1.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
42
291
1.51
1.61
8.7
9.5
%
95.6
95.5
0.01
42
281
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
32
2.54
1.61
1.4
2.6
nmol/l
3.8
2.6
—
8
32
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
206
1851
1.33
1.59
4.3
3.7
pmol/l
15.0
14.9
0.15
187
1634
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
42
292
1.51
1.59
1.5
1.4
—
—
—
0
0
(4268621)
7
26
2.73
1.59
2.4
2.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
20
3.04
1.59
1.0
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
216
2344
0.75
1.55
5.9
6.1
mmol/mol
40.4
40.4
0.01
190
2154
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
167
0.47
1.52
2.9
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
67
514
1.39
1.52
1.2
1.2
u/ml
0.5
1.4
1.32
14
132
(3020891) Body temperature
19
109
1.79
1.50
4.2
4.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
255
2376
1.39
1.48
32.4
14.6
ml/min/173m2
78.7
78.6
0.02
232
1956
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
141
1.68
1.46
12.0
13.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
38
264
1.50
1.45
9.5
10.1
g/l
118.0
120.1
0.26
38
256
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
22
2.76
1.44
1.3
1.5
u/l
11.8
14.9
—
6
22
(3035350) Ketones [Presence] in Urine by Test strip
141
1216
1.29
1.42
5.0
3.8
estimate
0.0
0.0
0.00
40
234
(3044927) Protein electrophoresis panel - Urine
7
29
2.45
1.40
1.0
1.1
—
—
—
0
0
(4094501)
12
60
2.04
1.40
1.2
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
82
1.87
1.38
1.4
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
42
2.18
1.35
3.0
2.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
18
106
1.74
1.32
7.7
9.7
%
0.8
0.9
0.83
18
98
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
24
2.53
1.31
1.5
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
24
2.53
1.31
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
34
2.39
1.30
1.5
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
180
1614
1.27
1.28
3.6
3.1
u/l
68.6
51.6
0.99
164
1499
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
44
2.08
1.28
1.4
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
96
799
1.29
1.25
2.1
2.1
u/l
154.9
226.1
0.57
91
750
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
18
108
1.71
1.25
7.7
9.5
%
1.5
1.6
0.24
18
100
(3009261) Glucose [Presence] in Urine by Test strip
142
1244
1.26
1.21
5.0
3.9
estimate
0.0
0.0
0.00
40
219
(3045424) Erythrocytes [Presence] in Urine
8
38
2.13
1.19
1.5
1.3
—
—
—
0
0
(4281824)
6
26
2.33
1.19
1.3
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
26
2.33
1.19
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
57
1.96
1.18
3.5
4.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
220
2354
0.78
1.18
4.2
4.2
mmol/l
1.3
1.3
0.86
195
2127
(3021601) Nitrite [Presence] in Urine by Test strip
140
1228
1.25
1.17
6.5
5.2
estimate
0.0
0.0
0.00
41
229
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
24
159
1.55
1.16
1.8
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
20
2.52
1.15
1.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
24
350
0.66
1.15
4.5
4.7
%
29.2
32.0
0.69
15
232
(21494755) Public health laboratory ask at order entry panel
10
179
0.54
1.09
1.5
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
74
1.79
1.08
2.8
2.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
52
1.95
1.07
1.2
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
34
248
1.42
1.05
2.0
2.6
ug/l
2.8
6.5
2.59
29
220
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
34
2.08
1.03
1.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
27
189
1.47
1.03
6.3
6.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
48
373
1.34
1.02
1.2
1.3
u/ml
3.7
14.2
1.56
14
138
(3022621) pH of Urine by Test strip
10
173
0.56
0.98
2.8
3.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
274
2624
1.35
0.98
35.6
18.4
mmol/l
139.3
139.7
2.12
268
2553
(3017732) Neutrophils [#/volume] in Blood
25
175
1.47
0.96
3.0
2.7
e9/l
3.7
4.0
0.22
20
130
(4306422)
6
27
2.25
0.94
1.2
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
274
2628
1.33
0.93
36.8
18.5
mmol/l
4.0
4.0
0.48
268
2556
(3026389) Candida sp identified in Specimen by Organism specific culture
6
28
2.16
0.92
1.2
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
23
160
1.47
0.92
2.0
2.4
—
15.7
—
0
6
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
109
955
1.22
0.88
5.3
4.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
30
2.02
0.87
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
64
1.74
0.87
1.5
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
277
2666
1.33
0.87
22.0
10.8
u/l
25.9
25.6
0.14
271
2561
(3000494) Fungus identified in Specimen by Culture
41
320
1.32
0.86
1.9
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
32
1.89
0.82
1.3
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
47
1.72
0.81
1.5
3.6
%
55.8
64.3
—
8
47
(3041096) Erythrocytes [Presence] in Urine by Automated
79
677
1.22
0.79
4.0
3.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
48
1.68
0.79
2.4
2.4
—
—
—
0
0
(3015736) pH of Urine
107
947
1.20
0.77
5.0
3.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
24
178
1.38
0.71
9.4
9.5
mmol/l
25.2
24.4
0.61
24
168
(1616796) Gas panel - Central venous blood
10
61
1.66
0.69
6.8
2.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
28
1.80
0.66
1.2
1.2
—
—
—
0
0
(3000492) Spirometry study
30
234
1.31
0.66
1.8
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
152
1403
1.16
0.64
2.9
2.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
23
173
1.36
0.64
1.2
1.2
—
—
—
0
0
(4010399)
24
183
1.34
0.61
1.3
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
30
1.68
0.61
1.2
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
13
89
1.48
0.59
2.9
3.4
g/l
0.1
0.2
—
8
33
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.2
—
94.4
—
0
5
(3049717) Cytology report of Urine Cyto stain
18
132
1.39
0.58
1.7
2.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
36
1.68
0.57
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
64
557
1.19
0.56
5.8
4.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
37
1.63
0.56
1.5
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
9
60
1.51
0.55
12.6
14.1
mmol/l
9.9
11.1
—
9
54
(3018572) Chloride [Moles/volume] in Blood
9
60
1.51
0.55
12.6
14.1
mmol/l
104.0
105.4
—
9
54
(3022145) Colonoscopy Study observation
36
297
1.24
0.53
1.4
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
63
1.44
0.52
2.4
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
48
410
1.20
0.51
1.2
1.3
iu/ml
39.2
35.6
0.05
13
122
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
237
2284
1.15
0.48
5.3
4.5
mu/l
2.0
2.0
0.17
219
2047
(3030981) Hyaline casts [#/volume] in Urine by Automated count
19
146
1.32
0.48
2.6
3.1
e6/l
0.5
0.2
0.43
19
141
(3051611) Lipemic interference index of Serum or Plasma
5
31
1.62
0.43
2.4
3.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
12
87
1.39
0.43
4.1
3.6
mmol/l
4.0
3.9
0.26
12
82
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
8
59
1.37
0.41
2.1
1.7
e6/l
2754.9
18958.0
—
8
45
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.0
—
32.7
—
0
10
(40768793) Breast Pathology biopsy report
10
71
1.42
0.39
1.5
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
19
0.00
0.39
0.0
2.4
—
—
—
0
0
(1002224) Polysomnography panel
12
89
1.36
0.38
1.0
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
62
557
1.14
0.38
1.7
1.8
pmol/l
469.5
438.2
0.39
50
446
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
112
0.71
0.38
2.1
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
37
1.36
0.37
7.0
4.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
197
0.80
0.32
1.2
2.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
7
57
1.23
0.29
1.1
1.5
mu/l
253.6
262.8
—
7
50
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
236
0.84
0.27
1.8
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
133
1.21
0.24
2.6
2.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
38
1.32
0.23
3.4
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
39
1.29
0.23
3.4
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
39
1.29
0.23
3.4
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
39
1.29
0.23
3.4
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
40
1.25
0.22
3.4
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
40
1.25
0.22
3.4
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
71
665
1.09
0.22
1.5
1.7
mmol/l
1.4
1.3
0.21
60
541
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
8.5
—
0.6
—
0
11
(3003129) Base excess in Capillary blood by calculation
0
10
0.00
0.21
0.0
1.1
—
2.6
—
0
10
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
14.7
—
1760.3
—
0
12
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
0.8
—
0
7
(3029075) Extractable nuclear Ab panel - Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
208
0.86
0.20
1.4
2.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
327
1.11
0.20
9.5
7.8
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.3
—
4.6
—
0
7
(3009508) Creatinine [Moles/volume] in Urine
86
817
1.07
0.19
3.1
3.1
mmol/l
7.1
7.4
0.27
66
670
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
91
1.22
0.18
1.9
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
131
0.83
0.17
4.8
3.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
8
71
1.13
0.16
30.1
2.9
kpa
7.8
7.9
—
8
64
(3019150) Specific gravity of Urine by Refractometry
58
547
1.07
0.16
5.4
4.4
kg/l
1.0
1.0
—
5
83
(1761482) Bacteria [#/volume] in Urine by Culture
6
78
0.76
0.15
6.0
4.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
75
781
0.95
0.12
3.4
3.3
mg/l
36.0
207.7
0.91
49
520
(3019225) pH of Specimen
28
259
1.09
0.12
5.6
4.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
55
573
0.95
0.09
3.1
3.0
ug/l
0.6
0.8
1.78
42
383
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
47
1.06
0.09
1.2
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
26
278
0.93
0.09
1.3
1.7
%
1.8
1.5
0.54
19
237
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
124
0.88
0.09
1.3
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
56
1.07
0.08
6.0
2.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
80
823
0.96
0.08
3.8
4.0
mg/mmol
5.5
7.7
0.74
53
527
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
143
0.91
0.07
1.5
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
20
186
1.08
0.07
15.2
3.7
kpa
5.1
5.1
0.07
20
173
(3045414) Leukocytes [Presence] in Urine
11
99
1.12
0.06
1.5
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
78
796
0.97
0.05
4.2
4.6
%
23.4
21.4
0.52
38
396
(3013512) EKG study
79
804
0.98
0.04
5.2
4.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
278
2770
1.03
0.03
47.0
22.9
e9/l
234.9
243.3
0.90
268
2698
(40761535) Cells panel - Urine sediment
24
231
1.04
0.03
5.6
3.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
246
2449
1.02
0.03
4.7
4.8
mmol/l
6.0
6.0
0.09
224
2210
(3026361) Erythrocytes [#/volume] in Blood
278
2771
1.03
0.02
47.0
22.9
e12/l
4.2
4.5
12.87
267
2689
(3010813) Leukocytes [#/volume] in Blood
278
2772
1.03
0.01
47.1
22.9
e9/l
7.8
6.7
1.12
266
2691
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
98
1.02
0.00
1.1
2.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
261
2611
1.00
0.00
24.2
14.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
20
203
0.98
0.00
1.8
2.5
ml/min/173m2
67.1
62.1
—
9
87
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
175
1.03
0.00
1.4
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
100
1004
0.99
0.00
4.7
5.1
ug/l
4.1
2.2
0.49
93
891
(3048689) Calprotectin [Mass/mass] in Stool
29
295
0.98
0.00
2.8
2.3
ug/g
156.8
124.6
0.13
23
226
(3022313) Gas panel - Capillary blood
13
134
0.97
0.00
19.7
3.9
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
57
0.88
0.00
1.6
1.7
pmol/l
183.8
227.7
—
5
52
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
9.6
—
0
9
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
82
0.97
0.00
1.3
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
79
0.88
0.00
1.6
1.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
59.6
—
0
5
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
19.4
—
0
7
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
79
1.01
0.00
1.1
2.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
7
0.00
0.00
0.0
2.1
—
2654.1
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS – Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).